Devgen (Euronext, Brussels: DEVG) - Disclosure in accordance with the
Transparency Legislation of May 2, 2007
Regulated Information
Gent (Belgium) - May 19, 2009 - According to Article 14 of the Law of
May 2, 2007 on the disclosure of major shareholdings in listed
companies, Devgen nv hereby informs that it received the following
notification of shareholding:
+-------------------------------------------------------------------+
| | | Number of | Number of | |
| | | voting rights | voting | % |
| | Denominator | before the | rights after | voting |
| | | transaction | the | rights |
| | | | transaction | |
|------------+-------------+----------------+--------------+--------|
| KBC Asset | | | | |
| Management | 17,891,734 | 558,863 | Not declared | <3 % |
| NV | | | | |
+-------------------------------------------------------------------+
The transaction is dated 30 April, 2009.
About Devgen
Devgen's mission is to enable farmers to sustainably grow more food
on less land, with less water, agrochemicals and labor.
Devgen uses advanced biotechnology and molecular breeding technology
to make high yielding seeds and crop protection solutions with a
superior environmental profile.
Devgen brings this technology to the market in the world's major food
and feed crops through two complementary strategies:
- Licensing Devgen technology for use in corn, cotton and soy and
selected other crops in exchange for R&D funding, and milestone and
royalty payments.
- Producing and selling its premium hybrid seeds in major field
crops such as rice, sunflower, sorghum, and pearl millet, in the
Indian subcontinent and S.E. Asia.
In its Crop Protection unit, Devgen develops a novel nematicide, an
agro-chemical product that protects crops from damage by parasitic
nematodes.
Incorporated in 1997, Devgen has offices in Ghent (Belgium),
Singapore, Hyderabad (India) and Delaware (US) and employs more than
200 people.
For more information please contact:
Thierry Bogaert, CEO Wim
Goemaere, CFO
Tel. +32 9 324.24.24 Tel.
+32 9324.24.24
Thierry.Bogaert@devgen.com
Wim.Goemaere@devgen.com
or visit: www.devgen.com
This press release may contain forward-looking statements containing
the words "anticipates", "expects" , "intends", "plans", "estimates",
"may" and "continues" as well as similar expressions. Such forward
looking statements may involve known and unknown risks, uncertainties
and other factors which might cause the actual results, performance
or achievements of Devgen to be materially different from any future
results or achievements expressed or implied by such forward-looking
statements. These forward looking statements speak only as of the
date of publication of this document. Devgen disclaims any obligation
to update such forward looking statements in this document to reflect
any change in its expectations, conditions or circumstances on which
such statement is based, unless required by law or regulation.
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
